Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Protalix Biotherapeutics (PLX)

Protalix Biotherapeutics (PLX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Protalix Biotherapeutics 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 ISR

P: 201-696-9345

Description:

Protalix BioTherapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of recombinant therapeutic proteins. The company's product pipeline includes ProCellEx(R). Protalix BioTherapeutics Inc. is based in CARMIEL, Israel.

Key Statistics

Overview:

Market Capitalization, $K 51,299
Shares Outstanding, K 47,063
Annual Sales, $ 38,350 K
Annual Net Income, $ -27,580 K
Last Quarter Sales, $ 16,090 K
Last Quarter Net Income, $ -2,290 K
60-Month Beta 1.92
% of Insider Shareholders 3.48%
% of Institutional Shareholders 12.56%
Float, K 45,425
% Float 96.52%
Short Volume Ratio 0.26

Growth:

1-Year Return -39.11%
3-Year Return -74.20%
5-Year Return -86.38%
5-Year Revenue Growth 316.85%
5-Year Earnings Growth 83.68%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.05 on 05/16/22
Next Earnings Date 08/15/22
Earnings Per Share ttm -0.53
EPS Growth vs. Prev Qtr 64.29%
EPS Growth vs. Prev Year 64.29%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 12/20/19

PLX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -29.24%
Profit Margin % -71.92
Net Margin % -267.37
Debt/Equity N/A
Price/Sales 1.33
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.16
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar